UBE2I and cancer: Considering that both Pin1-catalyzed isomerization and Ubc9-mediated sumoylation have several substrates, simultaneous targeting of Pin1 expression and Ubc9 isomerization may have outstanding anti-cancer effects in multiple cancers.